Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. (Q46750133)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

0 references

Heart failure with preserved ejection fraction

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Michael R Zile

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Peter E Carson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Robert McKelvie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Agata Ptaszynska

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Christoph Staiger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

J Mark Donovan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Barry M Massie

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Michel Komajda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

149-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18279770%20AND%20SRC:MED&resulttype=core&format=json

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Heart failure associated with preserved systolic function: a common and costly clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Systolic and diastolic heart failure in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Gender, age, and heart failure with preserved left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Outcome of heart failure with preserved ejection fraction in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Clinical practice. Diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) pro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010

Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2007.12.010